ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DANUTA JAGLA-SCHUDEL M.D.

Psychiatry

0

$0

0
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

0%
prescriptions for brand name drugs

Avg: 26%

$0
Average prescription price

Avg: $137

NIVES ANTOLOVIC-STANFEL M.D.

Psychiatry

0

$0

0
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

0%
prescriptions for brand name drugs

Avg: 26%

$0
Average prescription price

Avg: $137

ANNE HENDRICKS MD

Psychiatry

111

$12.6K

15
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

67%
prescriptions for brand name drugs

Avg: 26%

$114
Average prescription price

Avg: $137

MARK HEINE MD

Psychiatry

257

$13.9K

24
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $137

GARY POHL M.D.

Psychiatry

280

$29.8K

12
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 26%

$106
Average prescription price

Avg: $137

LARS JARSKOG MD

Psychiatry

297

$51.4K

20
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$173
Average prescription price

Avg: $137

JONATHAN LEINBACH MD

Psychiatry

307

$31.5K

21
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$103
Average prescription price

Avg: $137

JAMES GARBUTT MD

Psychiatry

308

$61K

17
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

65%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

60%
prescriptions for brand name drugs

Avg: 26%

$198
Average prescription price

Avg: $137

MICHELE DENKER MD

Psychiatry

321

$47.4K

43
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$148
Average prescription price

Avg: $137

CATHERINE MCCALL MD

Psychiatry

324

$30.8K

24
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 26%

$95
Average prescription price

Avg: $137

SHELDON CHASE M.D.

Psychiatry

333

$24.3K

32
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 26%

$73
Average prescription price

Avg: $137

DAVID TALLEY M.D.

Psychiatry

406

$46.5K

50
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 26%

$115
Average prescription price

Avg: $137

ANOOP KALIA M.D.

Psychiatry

413

$50.7K

26
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 26%

$123
Average prescription price

Avg: $137

MALTI MEHTA MD

Psychiatry

429

$129K

72
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

57%
prescriptions for brand name drugs

Avg: 26%

$300
Average prescription price

Avg: $137

JEFFREY CHAMBERS M.D.

Psychiatry

436

$38.6K

32
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 26%

$89
Average prescription price

Avg: $137

EDWARD ENTMACHER MD

Psychiatry

444

$34.1K

48
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 26%

$77
Average prescription price

Avg: $137

WILLIAM WILLIS MD

Psychiatry

446

$33.4K

34
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 26%

$75
Average prescription price

Avg: $137

GREGORY NARRON MD

Psychiatry

452

$71K

31
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 26%

$157
Average prescription price

Avg: $137

ELIZABETH STANTON MD, MBA

Psychiatry

462

$103K

47
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 26%

$224
Average prescription price

Avg: $137

LARRY BARNHILL M.D

Psychiatry

488

$54.7K

54
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 26%

$112
Average prescription price

Avg: $137

PHILIP NOFAL MD

Psychiatry

495

$47.7K

51
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 26%

$96
Average prescription price

Avg: $137

DANIEL JOHNSON MD

Psychiatry

497

$63.1K

36
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 26%

$127
Average prescription price

Avg: $137

MURALI JONNALAGADDA MD

Psychiatry

501

$66.2K

61
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 26%

$132
Average prescription price

Avg: $137

BRIAN SHEITMAN MD

Psychiatry

503

$64.2K

25
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 26%

$128
Average prescription price

Avg: $137

STEPHEN SANDERS M.D.

Psychiatry

514

$43.5K

55
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 26%

$85
Average prescription price

Avg: $137

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank